Modeling Tauopathy in the fruit fly Drosophila melanogaster.
暂无分享,去创建一个
[1] P. Hof,et al. Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.
[2] D. Selkoe,et al. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[3] Esther B. E. Becker,et al. Cell cycle regulation of neuronal apoptosis in development and disease , 2004, Progress in Neurobiology.
[4] C. Nüsslein-Volhard,et al. Mutations affecting segment number and polarity in Drosophila , 1980, Nature.
[5] D. Dias-Santagata,et al. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. , 2007, The Journal of clinical investigation.
[6] D. Dickson. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? , 2004, The Journal of clinical investigation.
[7] Wendy Noble,et al. Tyrosine 394 Is Phosphorylated in Alzheimer's Paired Helical Filament Tau and in Fetal Tau with c-Abl as the Candidate Tyrosine Kinase , 2005, The Journal of Neuroscience.
[8] R. Maccioni,et al. Subpopulations of tau interact with microtubules and actin filaments in various cell types , 1995, Cell biochemistry and function.
[9] Xiongwei Zhu,et al. Alzheimer's disease: the two-hit hypothesis , 2004, The Lancet Neurology.
[10] D. Rubinsztein,et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.
[11] Stephen M. Mount,et al. The genome sequence of Drosophila melanogaster. , 2000, Science.
[12] J. Shulman,et al. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila , 2007, Journal of neuroscience research.
[13] M. Feany,et al. Connecting cell-cycle activation to neurodegeneration in Drosophila. , 2007, Biochimica et biophysica acta.
[14] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[15] G. Johnson,et al. Tau, where are we now? , 2002, Journal of Alzheimer's disease : JAD.
[16] D. Dias-Santagata,et al. Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. , 2007, Molecular biology of the cell.
[17] S. Lovestone,et al. GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila , 2004, Molecular Psychiatry.
[18] Gloria Lee. Tau and src family tyrosine kinases. , 2005, Biochimica et biophysica acta.
[19] Leslie M Thompson,et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Jicha,et al. A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.
[21] Bin Zhang,et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Memo,et al. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? , 2001, Trends in Neurosciences.
[23] S. Jenkins,et al. Tau complexes with phospholipase C‐γ in situ , 1998 .
[24] D. Housman,et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.
[25] J. Shulman,et al. Genetic modifiers of tauopathy in Drosophila. , 2003, Genetics.
[26] Hyoung-Gon Lee,et al. Oxidative imbalance in alzheimer’s disease , 2007, Molecular Neurobiology.
[27] I. Grundke‐Iqbal,et al. Role of protein phosphatase‐2A and ‐1 in the regulation of GSK‐3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain , 2000, FEBS letters.
[28] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[29] G. Jicha,et al. Alz‐50 and MC‐1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau , 1997, Journal of neuroscience research.
[30] A Hirano,et al. Hirano bodies and related neuronal inclusions , 1994, Neuropathology and applied neurobiology.
[31] N. Perrimon,et al. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. , 1993, Development.
[32] D. Dickson,et al. Analysis of tauopathies with transgenic mice. , 2001, Trends in molecular medicine.
[33] H. Braak,et al. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. , 2003, The American journal of pathology.
[34] I. Vincent,et al. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases , 2000, Neurobiology of Aging.
[35] D. Dickson,et al. Neurodegenerative disorders with extensive tau pathology: A comparative study and review , 1996, Annals of neurology.
[36] Koichi M Iijima,et al. Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42. , 2008, Journal of Alzheimer's disease : JAD.
[37] G. Johnson,et al. Tau protein in normal and Alzheimer's disease brain. , 1999, Journal of Alzheimer's disease : JAD.
[38] C. Cotman,et al. Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.
[39] Ronald L. Davis,et al. Altered Representation of the Spatial Code for Odors after Olfactory Classical Conditioning Memory Trace Formation by Synaptic Recruitment , 2004, Neuron.
[40] G. Perry,et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. , 2008, CNS & neurological disorders drug targets.
[41] K. Herrup,et al. DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease , 2001, The Journal of Neuroscience.
[42] B. Winblad,et al. Levels of mTOR and its downstream targets 4E‐BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain , 2005, The FEBS journal.
[43] G. V. Van Hoesen,et al. Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.
[44] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[45] George Perry,et al. The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease , 2002, Neurosignals.
[46] D. Nanopoulos,et al. Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons. , 2004, Learning & memory.
[47] N. Plesnila,et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[48] S. Ackerman,et al. Oxidative stress, cell cycle, and neurodegeneration. , 2003, The Journal of clinical investigation.
[49] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[50] B. Winblad,et al. Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain , 2004, Neuroreport.
[51] K. Herrup,et al. Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models , 2006, The Journal of Neuroscience.
[52] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[53] E. Masliah,et al. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.
[54] Nancy M Bonini,et al. Drosophila as a model for human neurodegenerative disease. , 2005, Annual review of genetics.
[55] Leslie Michels Thompson,et al. Drosophila in the Study of Neurodegenerative Disease , 2006, Neuron.
[56] S. Lovestone,et al. Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions , 2005, Neurobiology of Disease.
[57] D. Selkoe. Alzheimer's Disease Is a Synaptic Failure , 2002, Science.
[58] D. Campion,et al. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. , 2007, Human molecular genetics.
[59] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[60] K. Lu,et al. Pinning down phosphorylated tau and tauopathies. , 2005, Biochimica et biophysica acta.
[61] Tudor A. Fulga,et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.
[62] J. Shulman,et al. TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model , 2006, Current Biology.
[63] B. Lu,et al. PAR-1 Kinase Plays an Initiator Role in a Temporally Ordered Phosphorylation Process that Confers Tau Toxicity in Drosophila , 2004, Cell.
[64] Miratul M. K. Muqit,et al. Modelling neurodegenerative diseases in Drosophila: a fruitful approach? , 2002, Nature Reviews Neuroscience.
[65] E. Mandelkow,et al. Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. , 2002, Molecular biology of the cell.